CytoDyn, Inc.


CytoDyn is a drug development company with a single, promising drug: Cytolin. Cytolin is in clinical trials for the treatment of HIV infection. Unlike currently-available anti-viral regimens, Cytolin acts by correcting HIVinduced errors in the human immune system that cause it to attack itself in the later stages of HIV infection. Early trials of the drug show great promise, with an excellent safety profile, few side effects, and a reduction in viral load of as much as 90%. The Company trades on the Pink Sheets and is based in Santa Fe, New Mexico.

Recent News


1511 Third Street
Santa Fe, NM 87505